Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Permian Resources Corporation Class A Common Stock (PR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Permian Resources Corporation Class A Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Permian Resources Corporation Class A Common Stock trades at $22.64 (market cap $18.57B). The key difference: Permian Resources Corporation Class A Common Stock is far larger — about 3.9× Definium Therapeutics Inc. Common Shares's market cap, and Permian Resources Corporation Class A Common Stock pays a 2.84% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Permian Resources Corporation Class A Common Stock for 0 Days on average.
| DFTX | PR | |
|---|---|---|
Market Cap | $4.71B | $18.57B |
Volume | 1,966,636 | 7,560,985 |
Sector | Health | Energy |
52-Week High | $48.45 | $24.49 |
52-Week Low | $10.68 | $12.09 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $21.57B |
Dividend Yield | — | 2.84% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Permian Resources Corporation Class A Common Stock
Permian Resources explores for and produces oil and natural gas in the Permian Basin. Its operations are concentrated in the Delaware Basin of West Texas and New Mexico.
Read more on PR →
